Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Nephrology Stories

2013-08-02 11:15:51

Significant costs arise even before patients develop kidney failure Even early stages of kidney disease come with steep medical costs, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study found that expenses related to moderate chronic kidney disease (CKD) cost Medicare tens of billions of dollars each year. Approximately 60 million people globally have CKD. Most of the costs of CKD are thought to arise when the...

2013-08-01 23:02:25

Bernstein Liebhard LLP is investigating GranuFlo lawsuits on behalf of dialysis patients who allegedly suffered catastrophic heart side effects, including heart attacks, strokes, and sudden cardiac death, related to the GranuFlo recall for GranuFlo and NaturaLyte dialysis concentrates. New York, New York (PRWEB) August 01, 2013 GranuFlo lawsuits (http://www.granuflodialysislawsuits.com/) filed in the wake of last year’s GranuFlo and NaturaLyte dialysis concentrate recall continue to...

2013-08-01 08:33:04

- National Kidney Foundation Recommends Annual Urine Screening for All Americans Over Age 60 - NEW YORK, Aug. 1, 2013 /PRNewswire/ -- Nearly six of ten Americans will develop kidney disease in their lifetime, according to a new analysis published in the American Journal of Kidney Diseases. In comparison, lifetime risk of diabetes, heart attack and invasive cancer is approximately four in ten. To view the multimedia assets associated with this release, please visit:...

2013-07-31 04:20:58

University of Leuven in Belgium first to use new solution for end-stage renal disease hemodialysis patients ATLANTA, July 31, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that the first European clinical implant of the Company's HeRO (Hemodialysis Reliable Outflow) Graft was performed at the University of Leuven Hospital in Belgium. The procedure was performed by...

2013-07-30 16:22:42

Leaders Warn That Proposed 12 Percent Reduction Will Lead to Facility Closures, Diminished Access and Quality WASHINGTON, July 30, 2013 /PRNewswire-USNewswire/ -- Basketball legend Alonzo Mourning is in Washington, DC, today for meetings with policy makers and elected officials to argue against proposed cuts to Medicare's dialysis benefit -- cuts that kidney care leaders warn will have negative consequences for patient access and quality. Mourning, who has kidney disease and had a...

Obese Patients Can Still Benefit From Kidney Transplants
2013-07-29 05:12:45

redOrbit Staff & Wire Reports - Your Universe Online Obese kidney failure patients who receive transplants experience the same overall survival benefit as their more physically fit counterparts, according to new research appearing in the latest edition of the American Journal of Transplantation. According to MedPage Today Contributing Writer Salynn Boyles, the study authors discovered renal failure patients who are obese but have a body mass index (BMI) score under 40kg/m2...

2013-07-26 12:17:19

Contact varies across countries, with US patients having particularly infrequent contact with physicians -The frequency and duration of patient-doctor contact during dialysis care vary appreciably across countries. -More frequent and longer contact with physicians is linked to fewer deaths and hospitalizations of dialysis patients. -Approximately 2 million patients in the world receive some sort of dialysis treatment. Both the frequency and duration of patient-doctor contact during...

2013-07-25 12:28:23

PRINCETON, N.J., July 25, 2013 /PRNewswire/ -- Guerbet announced today that Cincinnati Children's Hospital Medical Center (Cincinnati Children's) last week performed the first US injection of Dotarem(®) (gadoterate meglumine), the only macrocyclic and ionic gadolinium-based contrast agent (GBCA) approved by the US Food and Drug Administration. The procedure was performed in a school age child. Dotarem(®) is indicated for intravenous use with magnetic resonance imaging (MRI) in...

2013-07-23 23:32:02

Resource4thePeople encouraged by judge's selection of executive committee to oversee pre-trial evidence gathering over allegations that NaturaLyte and GranuFlo Dialysis products allegedly caused heart attacks. Resource4thePeople’s national team of attorneys continues offering complimentary consultations for consumers seeking legal options for possible compensation. San Diego, CA (PRWEB) July 23, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html...

2013-07-23 23:02:56

The Firm is investigating GranuFlo lawsuit claims on behalf of dialysis patients who allegedly suffered catastrophic heart side effects related to the GranuFlo recall for GranuFlo and NaturaLyte dialysis drugs. New York, New York (PRWEB) July 23, 2013 GranuFlo lawsuit claims filed in the wake of the recent recall of GranuFlo and NaturaLyte dialysis concentrates are moving forward in a federal multidistrict litigation now underway in U.S. District Court, District of Massachusetts,...


Latest Nephrology Reference Libraries

Hypertension (journal)
2012-05-14 11:48:30

Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...

More Articles (1 articles) »